- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Cystic Fibrosis (CF)
- Meeting Date: November 2019
- Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)
Tezacaftor with ivacaftor – November 2019
Tezacaftor with Ivacaftor: Tablet containing tezacaftor 100 mg with ivacaftor 150 mg; Symdeko®
Last updated
15 May 2020